Biotech
Isomorphic Labs
Isomorphic Labs raises $600M Series B at $3.5B valuation
$600M
Total Raised
Series B
Latest Round
2021
Founded
150+
Employees
London, UK
1 min read
Quick Facts
Valuation
$3.5B
Latest Round Size
$600M
Latest Round Date
March 2025
Isomorphic Labs: Series B Funding Round
Isomorphic Labs has successfully raised $600M in Series B funding, reaching a valuation of $3.5B.
Company Overview
AI-powered drug discovery platform applying machine learning to molecular design
Funding Details
The Series B round was led by Alphabet, with participation from Andreessen Horowitz.
Company Information
- Headquarters: London, UK
- Founded: 2021
- Employees: 150+
- Category: Biotech
Investment
Isomorphic Labs plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Alphabet: Verified investor in Series B
- Andreessen Horowitz: Verified investor in Series B
Key Investors
Alphabet
Lead Investor
Verified investor in Series B
Andreessen Horowitz
Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M